Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. by Wislet-Gendebien, Sabine et al.
Introduction
Stem cells have the capacity to self-replicate or to produce
progeny of one or several specific differentiated cell types.
They are not committed to a particular type of tissue and can
therefore generate cells belonging to different cell types. Two
types of stem cells have been identified: embryonic stem (ES)
cells, found in the inner cell mass of the early embryo, and
tissue-specific, including adult stem cells. Adult or somatic
stem cells have been located in bone marrow (Bianco et al.,
1999), blood (Domen et al., 1999), cornea and retina (Wu et
al., 2001), brain (Davis et al., 1994), skeletal muscles (Seale et
al., 2000), dental pulp (Gronthos et al., 2000), liver (Sell, 1990)
and skin (Gandarillas and Watt, 1997). Much information
concerning the characteristics of adult stem cells is derived
from studies of hematopoietic stem cells, because they are
easily isolated, abundant and widely used in the treatment of
several hematologic diseases and cancers.
Stem cells located in continuously renewing tissues such as
skin, gut or bone marrow, are able to regenerate or repair these
tissues throughout life. However, in the non-regenerating adult
central nervous system (CNS), neural stem cells (NSC) have a
poor capacity to generate new neurons or oligodendrocytes to
replace cells lost after injury or degeneration. In nervous
system disorders in which specific neuronal cell loss occur (e.g.
Parkinson’s disease) transplantation of neural cells allows for
the replacement of lost cells and recovery of some degree of
function (Freed et al., 2001).
Embryonic stem cells are totipotent and are thus able to
differentiate in any kind of cell type present during
development and in adulthood. At present, there is no evidence
that adult stem cells are totipotent, but some may have the
capacity to differentiate into phenotypes that belong to tissues
other than the one from which they originated, a property
usually referred to as plasticity or transdifferentiation. A
recently reported example of such plasticity is the finding that,
after intravascular delivery of genetically labelled adult mouse
bone marrow into lethally irradiated adult hosts, donor cells
expressing neuronal markers were found in the host CNS
(Brazelton et al., 2000). In vitro, a tiny fraction (2-5%) of bone
marrow stromal cells cultured in the presence of EGF or BDNF
express nestin, glial fibrillary acidic protein (GFAP) and
neuron-specific nuclear protein (NeuN) (Sanchez-Ramos et al.,
2000). The addition of dibutiryl cyclic AMP has been reported
to induce the differentiation of human mesenchymal stem cells
(MSCs) into early progenitors of neural cells (Deng et al.,
2001).
During the development of the CNS, proliferating
neuroepithelial cells express nestin (neural stem cells protein),
an intermediate filament protein (Lendahl et al., 1990), which
is also expressed by NSC in adult mammals and then used to
identify adult neural progenitors in culture (Dahlstrand, et al.,
1995). Although nestin is not a specific marker of neural stem
cells because it is also transiently expressed in muscle
progenitors and in some epithelial derivatives (Mokry and
Nemecek, 1998), the analysis of neurospheres obtained from
ES cells (which are known to be nestin-negative in vivo)
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Bone marrow stromal cells can differentiate into many
types of mesenchymal cells, i.e. osteocyte, chondrocyte and
adipocyte, but can also differentiate into non-mesenchymal
cells, i.e. neural cells under appropriate in vivo
experimental conditions (Kopen et al., 1999; Brazelton et
al., 2000; Mezey et al., 2000). This neural phenotypic
plasticity allows us to consider the utilization of
mesenchymal stem cells as cellular material in regenerative
medicine. In this study, we demonstrate that cultured adult
rat stromal cells can express nestin, an intermediate
filament protein predominantly expressed by neural stem
cells. Two factors contribute to the regulation of nestin
expression by rat stromal cells: serum in the culture
medium inhibits nestin expression and a threshold number
of passages must be reached below which nestin expression
does not occur. Only nestin-positive rat stromal cells are
able to form spheres when they are placed in the culture
conditions used for neural stem cells. Likewise, only nestin-
positive stromal cells are able to differentiate into GFAP
(glial fibrillary acidic protein)-positive cells when they are
co-cultivated with neural stem cells. We thus demonstrated
that adult rat stromal cells in culture express nestin in
absence of serum after passaging the cells at least ten times,
and we suggest that nestin expression by these cells might
be a prerequisite for the acquisition of the capacity to
progress towards the neural lineage.
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demonstrates that all the cells within those spheres express
nestin, suggesting that nestin expression is correlated to or is
coincident with the initiation of sphere formation (Tropepe et
al., 2001).
The use of MSCs in auto-graft protocols in neurological
diseases necessitates the identification of the molecular events
that are important for the induction of neural differentiation of
MSCs. We found that the presence of serum in the culture
medium represses nestin expression by rat stromal cells (rSCs).
Moreover, only nestin-positive rSCs are able to form
aggregates in suspension when they are transferred to NSCs
culture conditions. But, when those spheres or aggregates were
placed in culture conditions known to favour neural
differentiation of NSCs, only modifications of cell shape were
observed. In contrast, when nestin-positive rSCs were grown
in co-culture with mouse neural stem cells (mNSCs),
heterogenous spheres formed which, when plated on
polyornithine-coated surfaces, released 40% rSCs that
differentiated into GFAP-positive cells. Nestin-negative rSCs
cells, when grown in the same condition, gave rise to less than
5% GFAP-positive rSCs. Nestin expression by rSCs should
thus be regarded as a first step in their progression to the neural
lineage.
Materials and Methods
Preparation and culture of rat stromal cells
Adult rat bone marrow was obtained from femurs and tibias by
aspiration and was resuspended into 5 ml of DEM (Invitrogen,
Merelbeke, Belgium) (Azizi et al., 1998). Between 100 and 200 · 106
marrow cells were plated on 175-cm tissue culture flask in DEM/10%
foetal bovine serum (Invitrogen). After 24 hours, the non-adherent
cells were removed by replacing the medium. When the rSCs became
confluent, they were resuspended with 0.25% Trypsin and 1 mM
EDTA and then sub-cultured. To initiate nestin expression, the
cultures were washed with PBS and grown in DEM/F12 medium
(Invitrogen). After 3 days, the cells were fixed. rSCs were then
processed for immunocytochemistry or western blotting as described
below.
Preparation and culture of mNSCs
Green C57BL/6 mice embryos (Jackson Immunoresearch Laboratory,
West Grove, PA, USA) were used as a source of mNSC. In the green
mouse, GFP expression is under the b -actin promoter activity and
NSC can therefore be identified by their green fluorescence (Okabe
et al., 1997). The day of conception was determined by the presence
of a vaginal plug (embryonic day 0). E15 striata were isolated and
triturated in DEM/F12 (Invitrogen) with a sterile Pasteur pipette. The
cell suspension was filtered with a 70 m m-pore filter and viable cells
were estimated by trypan blue exclusion. The cells were plated (1· 106
cells/75-cm tissue culture flask) in DEM/F12 supplemented with
epidermal growth factor (EGF, 20 ng/ml, Sigma), N2 and B27
(Neurobasal medium, Invitrogen) which are two multicomponent cell
culture supplements devoid of any growth factor. When the size of
neurosphere reached approximately 50 cells, they were dissociated to
a single cell suspension by trituration and replated in fresh culture
medium.
Immunological characterization of rSCs
rSCs have been characterized by immunocytochemical labelling for
CD45 (Pharmingen, The Netherlands; 1:200), CD11b (Pharmingen;
1:200), Thy1.1 (Chemicon, Wevelgem, Belgium; 1:200) and P75
NGF-R (Chemicon; 1:200) (Goodell et al., 1997). Fluorescence-
activated cell sorting of first passage rSCs was performed with anti-
CD45 and anti-CD11b antibodies. Briefly, the cells were suspended
with 10 mM ice-cold EDTA (Fluka, Bornem, Belgium) and 500,000
cells were washed in 3 ml of PBS containing 1% foetal calf serum.
After centrifugation, the pellet was suspended in 200 m l of the primary
antibodies solutions, for 1 hour at room temperature. They were then
washed 3 times in PBS containing 1% foetal calf serum and incubated
with anti-mouse IgG (1:500) secondary antibody coupled to FITC
(Jackson Immunoresearch Laboratory) for 1 hour at room temperature
and in the dark. Before analysis using FACS, the cells were fixed by
a 15-minute incubation in 1% paraformaldehyde solution. The
analysis was performed with a FACSort instrument (Becton
Dickinson) and the results were analyzed using the Cellquest program
(Becton Dickinson).
Functional characterization of rSCs
The adipogenic differentiation of rSCs was induced by treatment with
1-methyl-3-isobutylxanthine (0.5 mM, Sigma, Belgium),
dexamethasone (1 m M, Sigma), bovine insulin (0.01 mg/ml) and
indomethacin (0.2 mM, Sigma). rSCs were placed in the above
adipocyte induction medium for 24 days. The differentiation was
evaluated by accumulation of lipid vacuoles and staining with Oil Red
O (Sigma) following fixation with 4% paraformaldehyde. To induce
osteocyte differentiation, the rSCs were incubated in DEM containing
dexamethasone (0.1 m M, Sigma), ascorbate (0.05 mM, Sigma) and b -
glycerophosphate (10 mM, Sigma) for 12 days. A significant increase
in alkaline phosphatase activity was measured with the alkaline
phosphatase colorimetric test, following the manufacturer’s
instructions (Sigma). Chondrogenic differentiation was induced with
DEM medium containing dexamethasone (0.1 m M, Sigma), sodium
pyruvate (1 mM, Janssen Chemica), ascorbic-2-phosphate acid (0.15
mM, Sigma), proline (0.35 mM, Sigma), bovine insulin (0.25 m g/ml),
selenic acid (6.25 m g/ml, Sigma) and linoleic acid (5.35 m g/ml,
Sigma). Chondrocytes were obtained when rSCs were grown as a
pellet in the induction medium for 20 days. The cell aggregates were
fixed with 4% paraformaldehyde, paraffin-embedded, cut at 5 m M
sections and stained with toluidine blue.
Induction of sphere formation by rSCs
After being induced to express nestin, rSCs were trypsinized and
suspended in DEM/F12 containing N2 and B27 supplements for 24
hours. During this time, the cells aggregated. These aggregates were
plated onto polyornithine-coated dishes for 5 days in the same
medium and were then processed for immunocytochemistry as
described below.
Co-culture rSCs and mNSC
Nestin-positive rSCs were trypsinized and were co-incubated with
GFP-positive mNSC (1· 106 mNSC and 1 · 104 rSCs) for 48 hours in
DEM/F12 containing EGF, N2 and B27 supplements. During this
time, the cells aggregated, forming heterogenous spheres. For a good
observation of the presence of rSCs into the heterogenous spheres, the
rSCs were colored in red with the DiD VybrantTM cell-labelling
solutions (Molecular Probes) following the manufacturer’s
instructions. These spheres were plated on polyornithine-coated
dishes for 5 days, in DEM/F12 containing N2 and B27 supplements
and were processed for immunocytochemistry as described below.
Nestin-negative rSCs were trypsinized and directly replated with
GFP-positive mNSC onto polyornithine-coated dishes for 5 days
following the same culture condition as described for the nestin-
positive cells. The cells were then processed for
immunocytochemistry.
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Immunocytochemistry
The cultures were fixed with 4% (v/v) paraformaldehyde for 15
minutes at room temperature and washed 3 times in TBS buffer. They
were then permeabilized in 1% Triton X-100 (v/v) for 15 minutes and
washed 3 times in TBS buffer. Non-specific binding was blocked by
a 1-hour treatment in TBST (TBS buffer with 0.1% Tween) containing
fat-free milk powder (30 mg/ml). The cells were then incubated for 1
hour at room temperature with either anti-p75/NGF-R, or anti-Thy1.1,
or anti-nestin (Rat401, Pharmingen; mouse IgG, dilution 1:1500), or
anti-GFAP (Dako; mouse IgG, dilution 1:500), or anti-M2
(Developmental Studies Hybridoma Bank; rat IgG, dilution 1:500), or
anti-GLAST (Shibata et al., 1997) (rabbit IgG, 1:4000) primary
antibodies (diluted in blocking buffer). After 3 washes, cells were
incubated in FITC- or Cy5-conjugated anti-mouse IgG (Jackson
Immunoresearch; 1:500) or rhodamine-conjugated anti-rat IgG
(Jackson Immunoresearch, 1:500) for 1 hour at room temperature and
in the dark. The nuclei were stained with ethidium homodimer (0.2
m M, Sigma). The preparations were then mounted in FluoprepTM
(bioMérieux, Marcy L’Etoile, France) and observed using a Bio-Rad
MRC1024 laser scanning confocal microscope.
Western blot
Total protein extracts were obtained from confluent cells that had been
cultured in the different media. The cells were harvested by scraping
the dish in 500 m l lysis buffer (0.6 M KCl, 5 mM EGTA, 5 mM EDTA,
1% Triton X-100 and 1 mM PMSF in PBS). Extracts were then
fractioned into pelletable (insoluble) and non-pelletable (soluble)
proteins by centrifugation at 30,000 g for 15 minutes at 4°C. The
pellet was resuspended in loading buffer (glycerol 10% v/v; Tris 0.05
M, pH 6.8; SDS 2%, bromophenol blue and 2.5% v/v b -
mercaptoethanol) and the suspension was centrifuged at 30,000 g for
15 minutes at 4°C. The supernatant was used for protein concentration
measurement using the RC DC Protein Assay (Bio-Rad). The same
protein quantities in each lane were separated by electrophoresis using
the Phastgel 4-15% SDS gradient (Amersham Pharmacia Biotech) and
transferred to a PVDF membrane. The membranes were saturated
with 3% gelatin (BioRad), incubated for 1 hour with a monoclonal
antibody against rat nestin (Pharmingen, 1:1,000) or b -actin, as
control for protein loading (Sigma, 1:5000) at room temperature and
then washed several times with PBS-0.1% Tween. The membrane was
then incubated in biotinylated goat anti-mouse antibody (Boehringher
Mannheim; 1:5000) for 1 hour at room temperature. After several
washes in PBS-0.1% Tween, the membrane was incubated with
peroxidase-coupled streptavidin (1:100,000, Sigma) at 37°C for 1
hour. Radial glial cells were used as a positive control for nestin
expression.
DNA ploidy
DNA content per cell was determined by FACS analysis after staining
the cells with propidium iodide. After 5 days of co-culture, rSCs and
mNSCs were trypsinised and fixed into 70% ethanol, at 4°C during
16 hours. The cells were stained with propidium iodide (400 m g/ml,
Sigma) just before FACS analysis.
Results
Immunological and functional characterization of rSCs
Rat stromal cells were isolated from the femoral and tibial
bones of adult rats and propagated in culture. rSCs have been
reported to be CD45- and CD11b-negative, but Thy1.1- and
P75 NGF-R-positive (Goodell et al., 1997). Fluorescent cell
sorting at passage 1 demonstrated that the cells were negative
for CD11b (Fig. 1A) and CD45 (Fig. 1B) – two cell surface
markers associated with lymphohematopoietic cells. In
contrast, immunofluorescent labeling demonstrated that 100%
of the rSCs were positive for Thy1.1 (Fig. 1C) and p75 NGF
receptor (Fig. 1D). Classically, SCs can differentiate either into
adipocytes, or chondrocytes and osteocytes (Pereira et al.,
1995; Kuznetsov et al., 2001; Prockop, 1997; Majumdar et al.,
1998; Pittenger et al., 1999). When our putative rSCs fraction
was placed in adipogenic, osteogenic and chondrogenic
induction media, adipocytes, osteocytes and chondrocytes,
respectively, were obtained (Fig. 1E-G).
Differentiation of rSCs into Nestin-positive cells
To induce neural differentiation of rSCs in long-term cultures,
we placed them in a classical NSC culture medium (DEM/F12
supplemented with N2 and B27). After 72 hours most rSCs
expressed nestin as revealed by immunocytochemistry (Fig.
2A). When rSCs are placed in DEM/F12 (Fig. 2B),
DEM/F12+N2 (Fig. 2C) and DEM/F12+B27 (Fig. 2D), the
same result is obtained, suggesting that the removal of serum
from the culture medium was actually responsible for the
induction of nestin expression by rSCs. These results were
confirmed by western blotting (Fig. 2F). In all of these
experiments, no alteration in the morphology of nestin-
positive SCs was observed. We demonstrated that the absence
of serum was necessary but not sufficient for the induction of
nestin expression. Indeed, the number of passages of rSCs in
vitro also regulates their ability to express nestin when grown
in serum-free condition (Fig. 3A-E): a minimum of ten
passages is needed before rSCs are able to express nestin when
placed in serum-free culture conditions. However, the capacity
of these cells to differentiate into adipocytes or osteocytes did
not change as a function of the number of passages (Fig.
3F,H).
Induction of sphere formation by rSCs
Recently, Tropepe et al. (Tropepe et al., 2001) suggested that
nestin expression by ES cells is correlated with the capacity to
form neurospheres and that ES cells have to go through a
nestin-expression stage before differentiating into neural cells.
When nestin-positive and nestin-negative rSCs were
trypsinised and replaced in an NSC growth medium
(DEM/F12, N2 and B27) in non-adherent conditions, we
observed that passage 15 nestin-positive rSCs aggregated in
suspension (Fig. 4A). In contrast, passage 4 nestin-negative
rSCs which had been cultivated in serum-free conditions for
48 hours prior to being transferred to NSCs growth medium,
remained in suspension and did not form spheres or aggregates
(Fig. 4B). Passage 15 rSCs that did not express nestin (because
they had been cultivated in serum-containing medium) adhered
spontaneously to the dish (Fig. 4C). We then plated the nestin-
positive rSCs aggregates on a polyornithine-coated surface for
5 days as is done for neurospheres in order to stimulate cell
differentiation. The cell morphology changed from the flat and
elongated shape of MSCs (Fig. 4D) to more rounded
morphology (Fig. 4E), but immunocytological labelling with
antibodies recognizing astrocytic (anti-GFAP, anti-GLAST),
oligodendroglial (anti-O4, anti-A2B5) and neuronal markers
(anti-NeuN, anti-NSE, anti-Tuj1, anti-MAP2B) were all
negative (data not shown). Moreover, after 5 days in these
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conditions, nestin expression decreased from 80% to 15%
(Fig. 4F).
Co-culture of rSCs and mNSCs
As nestin expression by rSCs appears insufficient to stimulate
their differentiation into neural cells, we have co-cultivated
nestin-positive rSCs with NSCs because the neural
differentiation of MSC has been observed mainly in vivo when
cells had been grafted in newborn mice brain. When we co-
cultivated nestin-positive red-labelled rSCs for 5 days with
NSCs obtained from E15 ‘green mouse’ striata (Okabe et al.,
1997), we observed that nestin-positive rSCs formed
heterogenous spheres (Fig. 5M) with the NSC. These
heterogenous spheres were then transferred on polyornithine-
coated dishes for 5 days to allow cellular differentiation.
Immunological labeling revealed the differentiation of
40– 2.39% nestin-positive rSCs into GFAP-expressing cells
(n=3, representing ~3000 cells) (Fig. 5A-C). A similar
percentage of GLAST-positive rSCs was also observed in these
conditions (Fig. 5G-I). However, no nestin-positive rSCs
expressed neuronal (anti-NeuN, anti-NSE, anti-Tuj1, anti-
MAP2B) or oligodendroglial markers (anti-O4, anti-A2B5)
(data not shown). Moreover, passage 4 nestin-negative rSCs
were unable to form heterogenous spheres, and when plated
directly with mNSC onto a polyornithine-coated surface, only
4% of them expressed GFAP (Fig. 5D-F). Three justifications
could be formulated to explain the GFAP expression by rSC:
1) a decrease of GFP expression in mNSCs, 2) a rSC-mNSC
fusion event, and 3) phenotypic plasticity of the rSCs. To
exclude a GFP downregulation, we cultivated GFP-positive
mNSC alone in the same conditions, and a GFAP
immunoreactivity was observed within GFP-positive cells (Fig.
5J-L). To exclude a cell fusion process, we first used antibody
M2, which specifically recognizes mouse-specific astrocytes
(Lagenaur and Schachner, 1981) to demonstrate that the GFP-
negative astrocytes that developed under these conditions were
of rat origin: no GFP-negative, GFAP-positive cells were
recognized by the M2 antibody, but the GFAP- and GFP-
positive cells were (Fig. 5N,O). Furthermore, we analyzed the
ploidy of the co-cultivated cells in order to determine if rSCs
adopt the astroglial phenotype of the recipient cells by a
hypothetical cell fusion event. We compared DNA ploidy of
the rSCs maintained in co-culture with mNSC for 5 days (Fig.
5P) with the DNA ploidy of rSCs and mNSC cultivated
separately for the same period, and we found the same DNA
content in the three cultures, thus excluding a cell fusion event.
Discussion
Cellular therapies are promising approaches in the treatment
of several neurological diseases such as Parkinson’s disease
(Isacson et al., 2001) or Huntington’s disease (Dunnett,
2000), but also for spinal cord injury (Hall, 2001), and, in
association with gene therapy, the treatment of glioma
(Armstrong et al., 2000; Isacson and Sladek, Jr, 1999). One
main problem concerns the origin and nature of the cells to
be used for such procedures. The ideal cell should exhibit
several key properties, including: (1) a high level of
proliferation in vitro, allowing the production of a large
number of cells from a minimal amount of donor material,
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Fig. 1. Immunological and functional characterization of
undifferentiated rSCs. FACS demonstrates that the cells are
negative for CD11b (A) and CD45 (B), two
lymphohematopoietic surface markers. Immunofluorescent
labelling shows that rSCs are positive for Thy1.1 (C) and p75
NGF receptor (D). Adipocyte induction was revealed by
accumulation of lipid vacuoles that were stained with Oil Red O
(E). Chondrocytes were obtained by culturing rSCs as a pellet
for 20 days in chondrocytic induction medium. Sections of the
paraffin-embedded cells were stained with toluidine blue. The
formation of cartilaginous structures is characterized by
differentiated chondrocytes in lacunae surrounded by
extracellular matrix (F). When rSCs were placed in osteocyte
induction medium, cells formed nodules (G) with multi-layered
regions, and a significant increase in alkaline phosphatase was
observed (H). Enzyme activity of the cells was measured in
triplicate cultures with the alkaline phosphatase colorimetric
test. In this test, the variation of the absorbency was measured as
a function of time at 405 nm. Scale bars: (C-E) 40 m m;
(F,G) 150 m m.
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(2) a good control of this proliferative activity in vivo, and
(3) a phenotypic plasticity allowing the differentiation into
appropriate neuronal or glial phenotype. The cells used for
transplantation into patients with neurological disorders have
hitherto been derived from the foetal human CNS. For
example, the cells grafted in Parkinson’s disease patients have
been obtained from foetal donors. They are isolated as post-
mitotic neurons from foetal mesencephalic tissue in which
dopaminergic neurons are normally found. This approach has
several pitfalls: a limited number of cells is available, grafted
patients need to be immunosuppressed, the material is not
easily available and there are a number of ethical problems
(Freed et al., 2001).
Several recent reports suggest that bone marrow stromal
cells could be a non-embryonic or non-foetal source of stem
cells suitable for cell replacement strategies in the treatment of
CNS disorders (Kopen et al., 1999; Akiyama et al., 2002a;
Akiyama et al., 2002b; Brazelton et al., 2000). An
understanding of the molecular regulation of such a
‘mesenchymal-neural’ transition may be very important when
considering the use of SCs in the treatment of CNS disorders.
In our study, rSCs have been isolated from adult rat bone
marrow using a differential adhesion procedure and selected by
their capacity of rapid proliferation. We demonstrate that these
stromal cells are able to express nestin. This expression is
dependent on two factors. The first one is the absence of serum-
derived components in the culture medium. Indeed, in our
study using western blot analysis and cell counting, higher
levels of nestin expression were found in serum-free
conditions, although RT-PCR and western blot demonstrate a
faint signal for nestin even in the presence of serum. The
second factor is the number of cell passages. A minimum of
ten passages is required for nestin expression by 75% of rSCs.
However, the capacity of rMSC to differentiate into adipocytes,
osteocytes or chondrocytes does not change as a function of
the number of passages. This requirement of 10 passages
(which correspond to 25 doubling populations) in vitro was
reproducible in 4 independent experiments.
Recently, Jiang et al. (Jiang et al., 2002),
demonstrated that rare cells within murine bone
marrow MSC cultures can differentiate not only
into the mesenchymal lineage cells but also into
endothelium, ectoderm and endoderm. These
rare cells, which have been named as multipotent
adult progenitor cells (or MAPCs), can be
expanded for more than 100 population
doublings, bringing about an enrichment in
MAPCs in MSCs culture. The increase in the
percentage of nestin-positive MSCs as a function of the number
of passages could possibly be explained by the presence of
these MAPCs in our cultures and their increase in number with
additional passages.
We show that only rSCs from nestin-positive cultures are
able to form clusters or aggregates in the non-adherent
conditions used to cultivate NSCs. Nestin expression by rSCs
and their ability to grow in suspension in such defined culture
conditions bring them nearer to the NSCs phenotype. However,
when nestin-positive rSCs spheres were plated onto an
adherent surface, no glial and/or neuronal differentiation was
observed. It seems that the complete neural differentiation of
MSCs observed in vivo, may require the involvement of several
induction signals which have not been reproduced in vitro. It
is for this reason that rSCs and NSCs were co-cultivated. It was
hoped that such an experiment would reproduce in vitro some
of the complex molecular interactions that are required to
induce a full neural differentiation of mesenchymal cells in
vivo.
Under these co-culture conditions, nestin-positive rSCs were
able to express GFAP, the astroglia-specific intermediate
filament protein, but also GLAST, another marker of astroglia
(Shibata et al., 1997). When nestin-negative rSCs were co-
cultivated with NSCs under identical conditions, a low
percentage of GFAP-positive cells of mesenchymal origin was
observed, suggesting that nestin expression is a prerequisite for
rSCs differentiation into a GFAP- or a GLAST-positive cell
type. This observation is in agreement with the notion that an
ordered succession of stimuli is needed to promote such a
differentiation.
Given the fact that it has been reported that 0.2-1 of ES cells
per 105 bone marrow cells can fuse with an other cell-type and
thus mimic a differentiation and/or plasticity (Terada and al.,
2002), we have excluded this possibility by two methods: first,
we could not find any mouse-specific antigenic labeling on
GFAP-positive cells of rSCs origin, and we exclude a
tetraploidy in our co-culture by FACS analysis. So, GFAP-
Fig. 2. Regulation of nestin expression by rSCs by
the serum. rSCs were cultivated in different culture
medium: DEM/F12+N2+B27 (A), DEM/F12 (B),
DEM/F12+N2 (C) or DEM/F12+B27 (D) and
DEM/10% FBS (E). Cultures were labeled with anti-
nestin antibody (green) and cell nuclei were
counterstained with ethidium homodimer (red). Scale
bar: (A-E) 40 m m. Nestin expression is present in
cells grown in all serum-free media, and this result
was confirmed by western blotting (F). Radial glial
cells (RGCs) were used as nestin-positive control and
b -actin was used as protein-loading control.
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Fig. 3. Regulation of nestin
expression by rSCs, by the number
of passages. rSCs express nestin
weakly between passage 0 and
passage 6 (A, rSCs passage 4). The
expression increases between
passage 6 and passage 10 (B, rSCs
passage 10). Beyond passage 11,
~75% of rSCs express nestin in
serum-free medium (C, rSCs
passage 15). Cultures were labeled
with nestin antibody (green
labelling) and cell nuclei were
counterstained with ethidium
homodimer (red labelling).
(D) The evolution of nestin
expression as function of the
number of passages of rSCs. This
graphic was established from
results of immunocytochemical
analysis on passage 4, 6, 7, 8, 9,
11, 14 and 15. In this experiment,
results are expressed as
percentages of nestin-positive cells
in each passage in serum-free
condition (n=4, representing a
minimum of 1500 counted cells in
each passage). These results were
confirmed by western blotting on
passage 4 (P4), 10 (P10) and 15
(P15) (E). Radial glial cells
(RGCs) were used as nestin-
positive control and actin was used
as protein-loading control. No
alteration of the capacity of
differentiation: (F) P10 adipocyte,
(G) P18 adipocyte, (H) osteocytes
can be observed even in the long-
term cultures. Scale bar: (A-C,F,G)
40 m m.
Fig. 4. Simultaneous nestin expression and aggregates formation.
After 72 hours incubation in serum-free medium, the cells were
trypsinised and resuspended in DEM/F12 with N2 and B27 for 24
hours. During that time, passage 15 cells aggregated to form clusters
or aggregates resembling neurospheres (A), whereas passage 4 rSCs
remained in suspension (B). Nestin-negative passage 15 cells
immediately adhere on the culture dish (C). The spheres obtained in
condition A were then placed on polyornithine for 5 days in
DEM/F12, N2 and B27 (E) where they exhibited a different
morphology than that observed in DEM/20% FBS medium (D).
Nestin immunocytochemistry (green) reveals that only 15% of the
cells still express nestin under these conditions (F). Scale bar:
(A-F) 40 m m.
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expression by rSCs are independent of cell-fusion events or
GFP downregulation in mNSC, but well a neural phenotypic
plasticity of rSCs.
In conclusion, nestin expression by rSCs should be regarded
as a first step in their progression to the neural lineage. A
better knowledge of the regulation of their differentiation into
astrocytes and the definition of appropriate culture conditions
to obtain their differentiation into neurons and/or
oligodendrocytes is still needed before considering MSCs as
an appropriate cellular material to be used for cell replacement
therapies in CNS disorders.
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confirmed with Glast marker (red) (G-I). Pure GFP-positive mNSC were used as a control to demonstrate that all GFAP (red)-positive cells
from mNSC remain GFP-positive (green) (J-L). A double-labelling with M2 (blue) and GFAP (red) antibodies allows the confirmation of the
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